Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles

Código QR

Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles

Dhananjayan Dhanasooraj, R Ajay Kumar, Sathish MundayoorMycobacterium Research Group, Rajiv Gandhi Centre for Biotechnology, Kerala, IndiaAbstract: Nano-sized hepatitis B virus core virus-like particles (HBc-VLP) are suitable for uptake by antigen-presenting cells. Mycobacterium tuberculosis antigen...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dhanasooraj D, Kumar RA, Mundayoor S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/06c6cd7b7b4f446a89cf34ce5a8225af
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein.
por: Aric L Gregson, et al.
Publicado: (2008)

Pigs Immunized with the Virus-like Particle Vaccine Are Protected against the Hepatitis E-3 Virus
por: Hyeon-Jeong Go, et al.
Publicado: (2021)

Chimeric hepatitis B virus core particles displaying Neisserial surface protein A confer protection against virulent Neisseria meningitidis serogroup B in BALB/c mice
por: Hou Y, et al.
Publicado: (2019)

Frequency of hepatitis B virus-DNA among hepatitis B surface-Ag negative, anti-hepatitis B core antibody-positive blood donors in Yazd, Iran
por: Mahtab Vaziri, et al.
Publicado: (2021)

Molecular basis of the interaction of the human tyrosine phosphatase PTPN3 with the hepatitis B virus core protein
por: Mariano Genera, et al.
Publicado: (2021)

Evaluation of exposure to nano-sized particles among transport and vehicle service workers
por: Stella Bujak-Pietrek, et al.
Publicado: (2021)

Activation of ERAD pathway by human hepatitis B virus modulates viral and subviral particle production.
por: Catalin Lazar, et al.
Publicado: (2012)

Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells
por: Matsuo H, et al.
Publicado: (2012)

Recombinant in vitro assembled hepatitis C virus core particles induce strong specific immunity enhanced by formulation with an oil-based adjuvant
por: ACOSTA-RIVERO,NELSON, et al.
Publicado: (2009)

Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
por: Jiyuan Zhou, et al.
Publicado: (2017)

Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
por: Percy A. Knolle, et al.
Publicado: (2021)

Extraction and Nano-Sized Delivery Systems for Phlorotannins to Improve Its Bioavailability and Bioactivity
por: Tianjian Tong, et al.
Publicado: (2021)

Size-Adjustable Nano-Drug Delivery Systems for Enhanced Tumor Retention and Penetration
por: Miao Deng, et al.
Publicado: (2021)

Assessing the efficacy of nano- and micro-sized magnetic particles as contrast agents for MRI cell tracking.
por: Arthur Taylor, et al.
Publicado: (2014)

Synthesis of core–shell copper–graphite submicronic particles and carbon nano-onions by spark discharges in liquid hydrocarbons
por: X. Glad, et al.
Publicado: (2021)

The role of PTEN - HCV core interaction in hepatitis C virus replication
por: Qi Wu, et al.
Publicado: (2017)

Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins
por: Marianela C. Serradell, et al.
Publicado: (2019)

Escherichia coli-derived virus-like particles in vaccine development
por: Xiaofen Huang, et al.
Publicado: (2017)

Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis.
por: Hui Liu, et al.
Publicado: (2021)

The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells
por: Andrew D. Huber, et al.
Publicado: (2018)

Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis
por: Hui Liu, et al.
Publicado: (2021)

Analysis of ultra-deep pyrosequencing and cloning based sequencing of the basic core promoter/precore/core region of hepatitis B virus using newly developed bioinformatics tools.
por: Mukhlid Yousif, et al.
Publicado: (2014)

Comparing the effects of nano-sized sugarcane fiber with cellulose and psyllium on hepatic cellular signaling in mice
por: Lian K, et al.
Publicado: (2012)

Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery
por: Petersen LK, et al.
Publicado: (2013)

Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle
por: Joshua M. Royal, et al.
Publicado: (2021)

Immune Response in Preterm Infants to Hepatitis B Vaccine
por: Y Zahedpasha, et al.
Publicado: (2011)

Adherence of community health workers to hepatitis B vaccination
por: Paula Kuster Pinto, et al.
Publicado: (2021)

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination
por: Slim Fourati, et al.
Publicado: (2016)

The response to Hepatitis B virus vaccine in HIV-infected patients (HIV/AIDS counseling and care center in Kermanshah)
por: K Alaei, et al.
Publicado: (2004)

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors
por: Vijeta Bajpai, et al.
Publicado: (2021)

Effects of hypoxia and nanocarrier size on pH-responsive nano-delivery system to solid tumors
por: M. Soltani, et al.
Publicado: (2021)

Endolysosomal targeting of a clinical chlorin photosensitiser for light-triggered delivery of nano-sized medicines
por: Elnaz Yaghini, et al.
Publicado: (2017)

The influence of nano MgO and BaSO4 particle size additives on properties of PMMA bone cement
por: Alyssa Ricker, et al.
Publicado: (2008)

Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel
por: Paolini M, et al.
Publicado: (2017)

Circadian control of hepatitis B virus replication
por: Xiaodong Zhuang, et al.
Publicado: (2021)

MOLECULAR-EPIDEMIOLOGICAL FEATURES OF HEPATITIS B VIRUS
por: V. V. Gerasimova, et al.
Publicado: (2016)

DNA Engineering and Hepatitis B Virus Replication
por: Chun-yang Gan, et al.
Publicado: (2021)

Dry powder cationic lipopolymeric nanomicelle inhalation for targeted delivery of antitubercular drug to alveolar macrophage
por: Vadakkan MV, et al.
Publicado: (2013)

Gating strategy for plasmablast enumeration after hepatitis B vaccination
por: M. G. Byazrova, et al.
Publicado: (2021)

Hepatitis B vaccine responsiveness and clinical outcomes in HIV controllers.
por: Jason F Okulicz, et al.
Publicado: (2014)